Survival in patients with type 2 diabetes in a Swedish community: Skaraborg Hypertension and Diabetes Project

Diabetes Care

Volumn 25, Issue 8, 2002, Pages 1297-1302

  Östgren, Carl Johan ^a,b   Lindblad, Ulf ^a,c   Melander, Arne ^a,d   Rastam, Lennart ^a,e  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b Odeshog Health Care Centre   (Sweden)

^c Skaraborgs Institutet   (Sweden)

^d Network for Pharmacoepidemiology Foundation   (Sweden)

^e SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; CONFIDENCE INTERVAL; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MALE; MEDICAL EXAMINATION; MICROALBUMINURIA; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POPULATION RESEARCH; PREDICTION; PRIMARY MEDICAL CARE; REGRESSION ANALYSIS; RISK FACTOR; SURVIVAL TIME; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; ALBUMINURIA; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; SEX RATIO; SURVIVAL RATE;

ALBUMINURIA; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; MALE; PRIMARY HEALTH CARE; PROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION; SURVIVAL RATE; SWEDEN;

EID: 0036673449     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.25.8.1297     Document Type: Article

References (45)

1. Morgan C, Currie C, Peters J: Relationship between diabetes and mortality: a population study using record linkage. Diabetes Care 23:1103-1107, 2000
2. Berger B, Stenström G, Sundkvist G: Incidence, prevalence, and mortality of diabetes in a large population: a report from the Skaraborg Diabetes Registry. Diabetes Care 22:773-778, 1999
3. UK Prospective Diabetes Study (UKPDS) Group: Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 352:837-853, 1998
4. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
5. Adler A, Stratton IM, Neil AW, Yudkin J, Matthews DR, Manley SE, Cull CA, Wright A, Turner RC, Holman R, on behalf of the UK Prospective Diabetes Study Group: Associations of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ 321:412-419, 2000
6. Staessen JA, Thijs L, Gasowski J, Cells H, Fagard RH: Treatment of isolated systolic hypertension in the elderly: further evidence from the systolic hypertension in Europe (Syst-Eur) trial. Am J Cardiol 12: 20R-22R, 1998
7. Hansson L, Zanchetti A, Carruthers G, Dahlöf B, Elmfeldt D, Julius S, Ménard J, Heinz K, Wedel H, Westerling S, for the HOT Study Group: Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. Lancet 351:1755-1762, 1998
8. Hansson L, Lindholm LH, Niskanen L, Lanke J, Hedner T, Niklasson A, Luomanmaki K, Dahlöf B, de Faire U, Morlin C, Karlberg BE, West PO, Björk JE: Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Catopril Prevention Project (CAPPP) randomised trial. Lancet 353:611-616, 1999
9. Stratton IM, Adler A, Neil AW, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman R, on behalf of the UK Prospective Diabetes Study Group: Associations of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405-412, 2000
10. Andersson D, Svärdsudd K: Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 18:1534-1543, 1995
11. Biderman A, Rosenblatt I, Rosen S, Zangwill L, Shalev R, Friger M, Weitzman S: Sex differentials in predictors of mortality for patients with adult onset diabetes: a population-based follow-up study in Beer-Sheva, Israel. Diabetes Care 23:602-605, 2000
12. Uusitupa MIJ, Niskanen LK, Siitonen O, Voutilainen E, Pyörälä K: Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 36:1175-1184, 1993
13. Schmitz A, Vaeth M: Microalbuminuria: a major risk factor in non-insulin-dependent diabetes: a 10-year follow-up study of 503 patients. Diabet Med 5:126-134, 1988
14. Turner RC, Millns H, Neil HAW, Stratton IM, Manley SE, Matthews DR, Holman RR: Risk factors for coronary artery disease in non-insulin dependant diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS 23). BMJ 316:823-828, 1998
15. Bøg-Hansen E, Lindblad U, Bengtsson K, Ranstam J, Melander A, Råstam L: Risk factor clustering in patients with hypertension and NIDDM. J Int Med 243:223-232, 1998
16. Berglund G, Isacsson S-O, Rydén L: The Skaraborg project: a controlled trial regarding the effect of structured hypertension care. Acta Med Scand 205 (Suppl.) 626:64-68, 1979
17. Råstam L, Berglund G, Isacsson S-O, Rydén L: The Skaraborg hypertension project. III. Influence on blood pressure of a medical care program for hypertension. Acta Med Scand 219:261-269, 1986
18. Lindblad U, Råstam L, Rydén L, Ranstam J, Berglund G, Isacsson S-O: Reduced stroke incidence with structured hypertension care: the Skaraborg Hypertension Project. J Hypertens 8:1147-1153, 1990
19. Lindblad U, Råstam L, Rydén L, Ranstam J, Isacsson S-O, Berglund G: Control of blood pressure and risk of myocardial infarction: Skaraborg hypertension project. BMJ 308:681-686, 1994
20. Östgren CJ, Lindblad U, Bøg-Hansen E, Ranstam J, Melander A, Råstam L: Differences in treatment and metabolic abnormalities between normo- and hypertensive patients with type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. Diabetes Obes Metab 1:105-112, 1999
21. Berger B, Stenstrom G, Chang YF, Sundkvist G: The prevalence of diabetes in a Swedish population of 280,411 inhabitants: a report from the Skaraborg Diabetes Registry. Diabetes Care 21:546-548, 1998
22. Eckerbom S, Bergqvist Y, Jeppson JO: Improved method for analysis of glycated haemoglobin by ion exchange chromatography. Ann Clin Biochem 31:355-360, 1994
23. Andersen L, Dinesen B, Jorgensen PN, Poulsen F, Roder ME: Enzyme immunoassay for intact human insulin in serum or plasma. Clin Chem 38:578-558, 1993
24. National Board of Health and Welfare, Drug Information Committee: Treatment of Mild Hypertension. Stockholm, Sweden, Socialstyrelsen, 1987
25. Spooren PF, Lekkerkerker JF, Vermes I: Micral-Test: a qualitative dipstick test for microalbuminuria. Diabetes Res Clin Pract 18:83-87, 1992
26. Byers T: Body weight and mortality. N Engl J Med 333:723-724, 1995
27. Desprès JP, Lamarche B, Mauriège P, Cantin B, Daganais GR, Moorjani S, Lupien PJ: Hyperinsulinemia as an independent risk factor for ischemic heart disease. N Engl J Med 334:952-957, 1996
28. Ferrara A, Barrett-Connor EL, Edelstein SL: Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernado Study, 1984-1991. Am J Epidemiol 140:857-869, 1994
29. Lillioja S, Mott DM, Spraul M, Ferraro R, Foley J, Ravussin E, Knowler W, Bennett P, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med 329:1988-1992, 1993
30. Martin B, Warram J, Krolewski A, Bergman R, Soeldner S, Kahn R: Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. Lancet 340:925-929, 1992
31. Reaven GM: Banting Lecture 1988: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988
32. Pi-Sunyer X: Weight and non-insulin-dependent diabetes mellitus. Am J Clin Nutr 63 (Suppl. 3):426S-429S, 1996
33. Wannamethee SG, Shaper AG: Weight change and duration of overweight and obesity in the incidence of type 2 diabetes. Diabetes Care 22:1266-1272, 1999
34. Colditz G, Willett W, Rotnitzky A, Manson J: Weight gain as a risk factor for clinical diabetes mellitus in women. Ann Intern Med 122:481-487, 1995
35. Fujimoto WY: The importance of insulin resistance in the pathogenesis of type 2 diabetes mellitus. Am J Med 17 (Suppl. 1):9-14, 2000
36. Haffner S, Miettinen H, Gaskill SP, Stern MP: Decreased insulin action and insulin secretion predict the development of impaired glucose tolerance. Diabetologia 39:1201-1207, 1996
37. Hypertension in Diabetes Study (HDS). I. Prevalence of hypertension in newly presenting type 2 diabetic patients and the association with risk factors for cardiovascular and diabetic complications. J Hypertens 11:309-317, 1993
38. Hypertension in Diabetes Study (HDS). II. Increased risk of cardiovascular complications in hypertensive type 2 diabetic patients. J Hypertens 11:319-325, 1993
39. Barrett-Connor EL, Cohn BA, Wingard DL, Edelstein SL: Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernado Study. JAMA 265:627-631, 1991
40. Avins AL, Neuhaus JM: Do triglycerides provide meaningful information about heart disease risk? Arch Intern Med 13:1937-1944, 2000
41. Sprecher D, Pearce G, Park E, Pashkow F, Hoogwerf B: Preoperative triglycerides predict post-coronary artery bypass graft survival in diabetic patients: a sex analysis. Diabetes Care 23:1648-1653, 2000
42. Ferrannini E, Haffner SM, Mitchell BD, Stern MP: Hyperinsulinemia: the key feature of a cardiovascular and metabolic syndrome. Diabetologia 34:416-422, 1991
43. Ezenwaka CE, Davis G: Increased risk of cardiovascular disease in newly diagnosed type 2 diabetic patients in a primary health care center in Trinidad. Diabetes Res Clin Pract 2:137-145, 2000
44. Bengtsson AK, Melander O, Orho M, Lindblad U, Ranstam J, Råstam L, Groop L: Beta(2)-adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37:1303-1308, 2000
45. Bengtsson AK, Orho M, Lindblad U, Melander O, Bog-Hansen E, Ranstam J, Råstam L, Groop L: Polymorphisms in the angiotensin converting enzyme but not in the angiotensinogen gene is associated with hypertension and type 2 diabetes: the Skaraborg Hypertension and Diabetes Project. J Hypertens 17:1569-1575, 1999